The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK

Prostate

Volumn 68, Issue 5, 2008, Pages 508-516

  Zhang, Zhisong ^a   Duan, Lei ^a   Du, Xiaoling ^a   Ma, Hongshun ^b   Park, Irwin ^c   Lee, Chung ^c   Zhang, Ju ^a   Shi, Jiandang ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN FIRST CENTRAL HOSPITAL   (China)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ER ; ERK; Estrogen; Proliferation; Prostatic stromal cell (PrSC)

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BOVINE SERUM ALBUMIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN; PROTEIN GPR 30; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE; SIGNAL TRANSDUCTION; STROMA CELL; WESTERN BLOTTING;

CELL PROLIFERATION; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GASTRIN-RELEASING PEPTIDE; HUMANS; MALE; PROSTATE; RECEPTORS, G-PROTEIN-COUPLED; RNA; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 41849097451     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20722     Document Type: Article

References (36)

1. Krieg M, Weisser H, Tunn S. Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH). Verh Dtsch Ges Pathol 1993;77:19-24.
2. Farhat MY, Abi-Younes S, Ramwell PW. Non-genomic effects of estrogen and the vessel wall. Biochem Pharmacol 1996;51(5):571-576.
3. Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER. Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem 2002;277(52):50768- 50775.
4. Rouayrenc JF, Vignon F, Bringer J, Pujol P. Non-genomic steroid effects: Estrogen action revisited. Ann Endocrinol (Paris) 2000;61(6)517-523.
5. Suzuki T, Yu HP, Hsieh YC, Choudhry MA, Bland KI, Chaudry IH. Estrogen-mediated activation of non-genomic pathway improves macrophages cytokine production following trauma-hemorrhage. J Cell Physiol 2008;214(3):662-672.
6. Walsh DE, Dockery P, Doolan CM. Estrogen receptor independent rapid non-genomic effects of environmental estrogens on [Ca2+]i in human breast cancer cells. Mol Cell Endocrinol 2005;230(1-2):23-30.
7. Zaitsu M, Narita S, Lambert KC, Grady JJ, Estes DM, Curran EM, Brooks EG, Watson CS, Goldblum RM, Midoro-Horiuti T. Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol 2007;44(8):1977-1985.
8. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA. Mechanisms of estrogen action. Physiol Rev 2001;81(4):1535-1565.
9. Luconi M, Muratori M, Forti G, Baldi E. Identification and characterization of a novel functional estrogen receptor on human sperm membrane that interferes with progesterone effects. J Clin Endocrinol Metab 1999;84(5):1670-1678.
10. Nadal A, Ropero AB, Fuentes E, Soria B. The plasma membrane estrogen receptor: Nuclear or unclear? Trends Pharmacol Sci 2001;22(12):597-599.
11. Watson CS, Pappas TC, Gametchu B. The other estrogen receptor in the plasma membrane: Implications for the actions of environmental estrogens. Environ Health Perspect 1995;103(Suppl 7):41-50.
12. Chen DB, Bird IM, Zheng J, Magness RR. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 2004;145(1):113-125.
13. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 2000;87(8):677-682.
14. Ropero AB, Soria B, Nadal A. A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol Endocrinol 2002;16(3):497-505.
15. Zhang Z, Maier B, Santen RJ, Song RX. Membrane association of estrogen receptor alpha mediates estrogen effect on MAPK activation. Biochem Biophys Res Commun 2002;294(5):926-933.
16. Zhang J, Hess MW, Thurnher M, Hobisch A, Radmayr C, Cronauer MV, Hittmair A, Culig Z, Bartsch G, Klocker H. Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markers. Prostate 1997;30(2):117-129.
17. Klinge CM, Blankenship KA, Risinger KE, Bhatnagar S, Noisin EL, Sumanasekera WK, Zhao L, Brey DM, Keynton RS. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem 2005;280(9):7460-7468.
18. Song RX, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen RJ. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and She pathway activation. Mol Endocrinol 2002;16(1):116-127.
19. Choudhury GG, Karamitsos C, Hernandez J, Gentilini A, Bardgette J, Abboud HE. PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF. Am J Physiol 1997;273(6 Pt 2):F931-F938.
20. Jin RM, Bai Y, Xiong AX, Lin W, Yu H, Wu XY, Fei HB. MAPK signal pathway plays a role in proliferation of jurkat cells induced by ouabain. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2005;13(1):126-129.
21. Kuo YR, Wu WS, Wang FS. Flashlamp pulsed-dye laser suppressed TGF-beta1 expression and proliferation in cultured keloid fibroblasts is mediated by MAPK pathway. Lasers Surg Med 2007;39(4):358-364.
22. Matthiesen S, Bahulayan A, Holz O, Racke K. MAPK pathway mediates muscarinic receptor-induced human lung fibroblast proliferation. Life Sci 2007;80(24-25):2259-2262.
23. Ishida M, Takahashi W, Itoh S, Shimodaira S, Maeda S, Arita J. Estrogen actions on lactotroph proliferation are independent of a paracrine interaction with other pituitary cell types: A study using lactotroph-enriched cells. Endocrinology 2007;148(7):3131-3139.
24. Shiozawa T, Miyamoto T, Kashima H, Nakayama K, Nikaido T, Konishi I. Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence. Oncogene 2004;23(53):8603-8610.
25. Zhao X, Huang L, Yin Y, Fang Y, Zhao J, Chen J. Estrogen induces endothelial progenitor cells proliferation and migration by estrogen receptors and PI3K-dependent pathways. Microvasc Res 2008;75(1):45-52.
26. Benitez DA, Pozo-Guisado E, Clementi M, Castellon E, Fernandez-Salguero PM. Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: Modulation of the phosphoinositide 3-kinase pathway. Br J Cancer 2007;96(10):1595-1604.
27. Ballif BA, Blenis J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 2001;12(8):397-408.
28. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004;68(2):320-344.
29. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995; 9(9):726-735.
30. Papatsoris AG, Papavassiliou AG. Molecular 'palpation' of BPH: A tale of MAPK signalling? Trends Mol Med 2001;7(7):288-292.
31. Kai L, Li-chun Z, Ping W. Expression of MAPKs in benign prostatic hyperplasia and its clinical significance. Prog Anat Sci 2005;11(3):203-205.
32. Björnström L, Sjöberg M. Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005;19(4):833-842.
33. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000;14(10):1649-1660.
34. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI. Estrogen action via the G protein-coupled receptor, GP R30: Stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 2002;16(1):70-84.
35. Filardo EJ, Thomas P. GP R30: A seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 2005;16(8):362-367.
36. Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D, Ando S. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 2004;279(26):27008-27016.